Common variants in WFS1 confer risk of type 2 diabetes

Article metrics

Abstract

We studied genes involved in pancreatic β cell function and survival, identifying associations between SNPs in WFS1 and diabetes risk in UK populations that we replicated in an Ashkenazi population and in additional UK studies. In a pooled analysis comprising 9,533 cases and 11,389 controls, SNPs in WFS1 were strongly associated with diabetes risk. Rare mutations in WFS1 cause Wolfram syndrome; using a gene-centric approach, we show that variation in WFS1 also predisposes to common type 2 diabetes.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Gloyn, A.L. et al. Diabetes 52, 568–572 (2003).

  2. 2

    Nielsen, E.M. et al. Diabetes 52, 573–577 (2003).

  3. 3

    Silander, K. et al. Diabetes 53, 1141–1149 (2004).

  4. 4

    Love-Gregory, L.D. et al. Diabetes 53, 1134–1140 (2004).

  5. 5

    Grant, S.F. et al. Nat. Genet. 38, 320–323 (2006).

  6. 6

    Minton, J.A. et al. Diabetes 51, 1287–1290 (2002).

  7. 7

    Inoue, H. et al. Nat. Genet. 20, 143–148 (1998).

  8. 8

    Strom, T.M. et al. Hum. Mol. Genet. 7, 2021–2028 (1998).

  9. 9

    Riggs, A.C. et al. Diabetologia 48, 2313–2321 (2005).

  10. 10

    Ishihara, H. et al. Hum. Mol. Genet. 13, 1159–1170 (2004).

  11. 11

    Karasik, A. et al. Diabetes Care 12, 135–138 (1989).

  12. 12

    Yamada, T. et al. Hum. Mol. Genet. 15, 1600–1609 (2006).

  13. 13

    Ozcan, U. et al. Science. 313, 1137–1140 (2006).

  14. 14

    Altshuler, D. et al. Nat. Genet. 26, 76–80 (2000).

Download references

Acknowledgements

We thank all study participants. We acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the UK Medical Research Council (MRC) grant G0000934 and the Wellcome Trust grant 068545/Z/02. The Ashkenazi population was collected by the Israeli Diabetes Research Group, funded by the Russell Berrie Foundation, D-Cure, Diabetes Care in Israel, Israel Ministry of Health and an unrestricted research grant from Novo-Nordisk. The Wellcome Trust and Diabetes UK funded the Warren 2 study. The work on the Cambridgeshire case-control, Ely, ADDITION and EPIC-Norfolk studies was funded by support from the Wellcome Trust and MRC. We are grateful to S. Griffin, MRC Epidemiology Unit for assistance with the ADDITION study and to S. O'Rahilly and M. Sampson for their contribution to the Warren 2 study. The UK type 2 diabetes case/control collection (Go-DARTS2) was funded by the Wellcome Trust. C.N.A.P. and A.D.M. are supported by the Scottish Executive Chief Scientist's Office as part of the Generation Scotland initiative. Illumina genotyping was done by P. Deloukas's laboratory at the Wellcome Trust Sanger Institute. I. Blech. and K.A.F. are funded by the Wellcome Trust. I.B. acknowledges support from EU FP6 funding (contract number LSHM-CT-2003-503041). A.T.H. is a Wellcome Trust Research Leave Fellow. M.N.W. is a Vandervell Foundation Research Fellow. S.L.D. is funded by the British Heart Foundation. None of the sponsors or funders had any role in the design and conduct of the study, in the collection, analysis and interpretation of the data or in the preparation, review or approval of the manuscript.

Author information

I. Barroso, A.T.H., M.A.P., N.J.W. and M.S.S. designed this study; M.S.S. did the statistical analysis, supported by I. Barroso, A.D., S.L.D., K.A.F., H.L., R.J.N., P.D.P., R.S. and M.N.W. M.S.S. wrote the manuscript with I. Barroso, S.L.D. and K.A.F.; A.D. conducted the bioinformatic analysis; I. Blech., S.L.D., K.A.F. and C.K. arrayed and genotyped the replication studies; B.G., A.T.H., G.H., C.K., A.D.M., M.I.M., C.N.A.P., M.W., R.T., J.W. and N.J.W. provided study samples and all authors contributed to data interpretation and commented on the final manuscript.

Correspondence to Manjinder S Sandhu or Inês Barroso.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–2, Supplementary Tables 1–4, Supplementary Methods (PDF 377 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sandhu, M., Weedon, M., Fawcett, K. et al. Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet 39, 951–953 (2007) doi:10.1038/ng2067

Download citation

Further reading